[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2016 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -9.21%
YoY- -30.49%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 2,473,176 2,189,022 2,141,608 2,181,982 2,236,780 2,189,312 2,012,216 14.72%
PBT 111,108 72,017 90,597 96,050 106,152 112,722 118,673 -4.29%
Tax -34,076 -26,158 -28,252 -27,828 -32,272 -28,138 -27,282 15.96%
NP 77,032 45,859 62,345 68,222 73,880 84,584 91,390 -10.75%
-
NP to SH 75,692 45,599 61,913 66,748 73,516 84,044 90,642 -11.31%
-
Tax Rate 30.67% 36.32% 31.18% 28.97% 30.40% 24.96% 22.99% -
Total Cost 2,396,144 2,143,163 2,079,262 2,113,760 2,162,900 2,104,728 1,920,825 15.86%
-
Net Worth 544,360 531,169 530,907 524,041 515,906 529,482 534,070 1.27%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 41,475 41,457 44,889 46,604 41,417 77,674 79,389 -35.10%
Div Payout % 54.79% 90.92% 72.50% 69.82% 56.34% 92.42% 87.59% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 544,360 531,169 530,907 524,041 515,906 529,482 534,070 1.27%
NOSH 259,219 259,377 258,979 258,913 258,859 258,915 258,880 0.08%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 3.11% 2.09% 2.91% 3.13% 3.30% 3.86% 4.54% -
ROE 13.90% 8.58% 11.66% 12.74% 14.25% 15.87% 16.97% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 954.09 844.83 826.94 842.74 864.09 845.57 777.28 14.62%
EPS 29.20 17.60 23.91 25.78 28.40 32.46 35.01 -11.38%
DPS 16.00 16.00 17.33 18.00 16.00 30.00 30.67 -35.16%
NAPS 2.10 2.05 2.05 2.024 1.993 2.045 2.063 1.19%
Adjusted Per Share Value based on latest NOSH - 258,981
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 171.60 151.88 148.59 151.39 155.20 151.90 139.62 14.72%
EPS 5.25 3.16 4.30 4.63 5.10 5.83 6.29 -11.34%
DPS 2.88 2.88 3.11 3.23 2.87 5.39 5.51 -35.08%
NAPS 0.3777 0.3685 0.3684 0.3636 0.358 0.3674 0.3706 1.27%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 4.89 5.30 5.58 5.50 5.76 6.36 6.50 -
P/RPS 0.51 0.63 0.67 0.65 0.67 0.75 0.84 -28.27%
P/EPS 16.75 30.12 23.34 21.33 20.28 19.59 18.56 -6.60%
EY 5.97 3.32 4.28 4.69 4.93 5.10 5.39 7.04%
DY 3.27 3.02 3.11 3.27 2.78 4.72 4.72 -21.68%
P/NAPS 2.33 2.59 2.72 2.72 2.89 3.11 3.15 -18.19%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 -
Price 4.72 5.12 5.70 5.62 5.60 6.19 6.50 -
P/RPS 0.49 0.61 0.69 0.67 0.65 0.73 0.84 -30.16%
P/EPS 16.16 29.09 23.84 21.80 19.72 19.07 18.56 -8.81%
EY 6.19 3.44 4.19 4.59 5.07 5.24 5.39 9.65%
DY 3.39 3.13 3.04 3.20 2.86 4.85 4.72 -19.78%
P/NAPS 2.25 2.50 2.78 2.78 2.81 3.03 3.15 -20.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment